Skip to main content

Peer Review reports

From: A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Original Submission
11 Nov 2013 Submitted Original manuscript
18 Dec 2013 Reviewed Reviewer Report - Maria Helena Rigatto
19 Dec 2013 Reviewed Reviewer Report - Samuel Wilson
20 Feb 2014 Author responded Author comments - Martin Stryjewski
Resubmission - Version 2
20 Feb 2014 Submitted Manuscript version 2
23 Mar 2014 Reviewed Reviewer Report - Maria Helena Rigatto
28 Mar 2014 Reviewed Reviewer Report - Samuel Wilson
23 Apr 2014 Author responded Author comments - Martin Stryjewski
Resubmission - Version 3
23 Apr 2014 Submitted Manuscript version 3
Publishing
24 Apr 2014 Editorially accepted
23 May 2014 Article published 10.1186/1471-2334-14-289

You can find further information about peer review here.

Back to article page